ADDEX THERAPEUTICS LTD (ADXN) Stock Cash Flow
NASDAQ:ADXN - Nasdaq - US00654J2069 - ADR - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 5.40M | -10.56M | -20.80M | -15.35M | -12.86M | |||
| Depreciation Amortization | 315.70K | 305.95K | 323.14K | 347.61K | 378.75K | |||
| Change In Working Capital | -84.36K | 213.76K | 157.68K | -761.57K | -1.82M | |||
| Interest Paid | 16.09K | 21.61K | 48.90K | 63.01K | 69.50K | |||
| Other non cash items | -11.61M | 2.04M | 3.89M | 1.06M | 2.12M | |||
| OPERATING CASH FLOW | -5.97M | -7.99M | -16.44M | -14.71M | -12.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.47K | -6.84K | -580.00 | -31.55K | -59.41K | |||
| Other Investing Activity | N/A | 0.00 | 3.55K | 1.24K | 0.00 | |||
| INVESTING CASH FLOW | 4.66M | -6.84K | 2.97K | -30.31K | -59.41K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -140.97K | -281.79K | -288.08K | -309.62K | -367.41K | |||
| Stock Issued/Repurchased | -5.79K | 4.49M | 3.99M | 19.04M | 720.01K | |||
| Other Financing Activity | 195.05K | 1.06M | -599.25K | -2.33M | -306.20K | |||
| FINANCING CASH FLOW | 48.29K | 5.26M | 3.10M | 16.40M | 46.40K | |||
| Exchange Rate Effect | -140.11K | -356.95K | -196.23K | 122.47K | -648.68K | |||
| CHANGE IN CASH | -1.40M | -3.09M | -13.53M | 1.79M | -12.84M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -5.97M | -7.99M | -16.44M | -14.71M | -12.18M | |||
| Capital Expenditure | -2.47K | -6.84K | -580.00 | -31.55K | -59.41K | |||
| FREE CASH FLOW | -5.98M | -8.00M | -16.44M | -14.74M | -12.24M | |||
All data in CHF